DRW Securities LLC Invests $1.38 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

DRW Securities LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the second quarter, according to its most recent filing with the SEC. The firm purchased 14,930 shares of the exchange traded fund’s stock, valued at approximately $1,384,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AE Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 13.3% in the 2nd quarter. AE Wealth Management LLC now owns 11,184 shares of the exchange traded fund’s stock worth $1,037,000 after purchasing an additional 1,314 shares during the period. LHM Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 22.3% in the second quarter. LHM Inc. now owns 45,775 shares of the exchange traded fund’s stock valued at $4,244,000 after purchasing an additional 8,361 shares in the last quarter. Brighton Jones LLC acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $208,000. LJI Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth about $1,890,000. Finally, Mercer Global Advisors Inc. ADV raised its position in SPDR S&P Biotech ETF by 40.6% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 11,128 shares of the exchange traded fund’s stock valued at $1,032,000 after buying an additional 3,214 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8 %

Shares of XBI stock opened at $101.61 on Monday. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The company’s fifty day simple moving average is $99.03 and its 200-day simple moving average is $93.90. The firm has a market cap of $7.74 billion, a PE ratio of 11.47 and a beta of 1.11.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.